Article
Alhydrogel TM , a widely used adjuvant, modulates multiple networks implicated in brain aging and has potential in the prevention of age-related cognitive decline
2026-05-25
Abstract excerpt
<title>Abstract</title> <p> <bold>BACKGROUND:</bold> A preliminary efficacy trial in early Alzheimer’s Disease (AD) serendipitously revealed that Alhydrogel <sup>®</sup> (alum) treated controls showed preservation of cognition, function, and hippocampal volume, with early onset and striking effect size. Aging is the highest risk factor for developing AD. We propose repurposing Alhydrogel <sup>®</sup> , form...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 27856455-c39b-5c67-9aa1-af7d8f03483c
- DOI
- 10.21203/rs.3.rs-9541548/v1
